{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:20:59Z","timestamp":1790493659523,"version":"4.1.0"},"reference-count":30,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,10,11]],"date-time":"2012-10-11T00:00:00Z","timestamp":1349913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Pathology"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pediatric high\u2010grade astrocytomas (<jats:styled-content style=\"fixed-case\">HGAs<\/jats:styled-content>) account for 15\u201320% of all pediatric central nervous system tumors. These neoplasms predominantly involve the supratentorial hemispheres or the pons\u2014diffuse intrinsic pontine gliomas (<jats:styled-content style=\"fixed-case\">DIPG<\/jats:styled-content>). Assumptions that pediatric <jats:styled-content style=\"fixed-case\">HGAs<\/jats:styled-content> are biologically similar to adult <jats:styled-content style=\"fixed-case\">HGAs<\/jats:styled-content> have recently been challenged, and the development of effective therapeutic modalities for <jats:styled-content style=\"fixed-case\">DIPG<\/jats:styled-content> and supratentorial <jats:styled-content style=\"fixed-case\">HGA<\/jats:styled-content> hinges on a better understanding of their biological properties. Here, 20 pediatric <jats:styled-content style=\"fixed-case\">HGAs<\/jats:styled-content> (9 <jats:styled-content style=\"fixed-case\">DIPGs<\/jats:styled-content> and 11 supratentorial <jats:styled-content style=\"fixed-case\">HGAs<\/jats:styled-content>) were subject to gene expression profiling following approval by the research ethics board at our institution. Many of these tumors showed expression signatures composed of genes that promote <jats:styled-content style=\"fixed-case\">G1\/S<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">G2\/M<\/jats:styled-content> cell cycle progression. In particular, Aurora kinase <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">AURKB<\/jats:styled-content>) was consistently and highly overexpressed in 6\/9 <jats:styled-content style=\"fixed-case\">DIPGs<\/jats:styled-content> and 8\/11 <jats:styled-content style=\"fixed-case\">HGAs<\/jats:styled-content>. Array data were validated using quantitative real\u2010time <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content> and immunohistochemistry, as well as cross\u2010validation of our data set with previously published series. Inhibition of Aurora <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> activity in <jats:styled-content style=\"fixed-case\">DIPG<\/jats:styled-content> and in pediatric <jats:styled-content style=\"fixed-case\">HGA<\/jats:styled-content> cell lines resulted in growth arrest accompanied by morphological changes, cell cycle aberrations, nuclear fractionation and polyploidy as well as a reduction in colony formation. Our data highlight <jats:styled-content style=\"fixed-case\">A<\/jats:styled-content>urora <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content> as a potential therapeutic target in <jats:styled-content style=\"fixed-case\">DIPG<\/jats:styled-content>.<\/jats:p>","DOI":"10.1111\/j.1750-3639.2012.00633.x","type":"journal-article","created":{"date-parts":[[2012,9,13]],"date-time":"2012-09-13T10:55:10Z","timestamp":1347533710000},"page":"244-253","source":"Crossref","is-referenced-by-count":34,"title":["<scp>A<\/scp>urora Kinase <scp>B<\/scp> Is a Potential Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma"],"prefix":"10.1111","volume":"23","author":[{"given":"Pawel","family":"Buczkowicz","sequence":"first","affiliation":[{"name":"Division of Pathology The Hospital for Sick Children  Toronto ON Canada"},{"name":"The Arthur and Sonia Labatt Brain Tumour Research Centre The Hospital for Sick Children  Toronto ON Canada"},{"name":"Department of Laboratory Medicine and Pathobiology Faculty of Medicine University of Toronto  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Zarghooni","sequence":"additional","affiliation":[{"name":"Division of Pathology The Hospital for Sick Children  Toronto ON Canada"},{"name":"The Arthur and Sonia Labatt Brain Tumour Research Centre The Hospital for Sick Children  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Bartels","sequence":"additional","affiliation":[{"name":"Division of Haematology &amp; Oncology The Hospital for Sick Children  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Morrison","sequence":"additional","affiliation":[{"name":"Division of Pathology The Hospital for Sick Children  Toronto ON Canada"},{"name":"The Arthur and Sonia Labatt Brain Tumour Research Centre The Hospital for Sick Children  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Misuraca","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Cancer Biology Duke University  Durham NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Chan","sequence":"additional","affiliation":[{"name":"The Arthur and Sonia Labatt Brain Tumour Research Centre The Hospital for Sick Children  Toronto ON Canada"},{"name":"Department of Laboratory Medicine and Pathobiology Faculty of Medicine University of Toronto  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bouffet","sequence":"additional","affiliation":[{"name":"Division of Haematology &amp; Oncology The Hospital for Sick Children  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Haematology &amp; Oncology The Hospital for Sick Children  Toronto ON Canada"},{"name":"The Arthur and Sonia Labatt Brain Tumour Research Centre The Hospital for Sick Children  Toronto ON Canada"},{"name":"Department of Laboratory Medicine and Pathobiology Faculty of Medicine University of Toronto  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Becher","sequence":"additional","affiliation":[{"name":"Division of Pediatric Hematology\/Oncology Duke University Medical Center  Durham NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Division of Pathology The Hospital for Sick Children  Toronto ON Canada"},{"name":"The Arthur and Sonia Labatt Brain Tumour Research Centre The Hospital for Sick Children  Toronto ON Canada"},{"name":"Department of Laboratory Medicine and Pathobiology Faculty of Medicine University of Toronto  Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,10,11]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.10.013"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-010-0224-7"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005209"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-2503"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.11.3052"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.9-2-197"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-009-0838-3"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543780902806392"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-07-2051"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0765"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200208091"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.6599"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s003810050542"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(06)70615-5"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1003"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200208092"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1215\/15228517-2008-113"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.54.5.815"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2009.03.009"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2964"},{"key":"e_1_2_6_22_1","first-page":"296","article-title":"VX680\/MK\u20100457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma","volume":"2","author":"Li Y","year":"2010","journal-title":"Am J Transl Res"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.7252"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.5677"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.02.019"},{"key":"e_1_2_6_26_1","first-page":"25731","article-title":"Clonogenic assay: adherent cells","volume":"13","author":"Rafehi H","year":"2011","journal-title":"J Vis Exp"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.198"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3597"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00381-008-0740-3"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.5463"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2006.036806"}],"container-title":["Brain Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1750-3639.2012.00633.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1750-3639.2012.00633.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T18:21:25Z","timestamp":1697394085000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1750-3639.2012.00633.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,11]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1111\/j.1750-3639.2012.00633.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1750-3639.2012.00633.x","archive":["Portico"],"relation":{},"ISSN":["1015-6305","1750-3639"],"issn-type":[{"value":"1015-6305","type":"print"},{"value":"1750-3639","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,11]]}}}